CRISPR Therapeutics AG News

Latest updates and market news for CRSP

9 news

Mar 11 - Mar 17, 2026

Page 1

A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering

Simply Wall St.

3 days ago

A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering

Is CRISPR Therapeutics (CRSP) Pricing Reflecting Gene Editing Potential After Recent Share Pullback

Simply Wall St.

3 days ago

Is CRISPR Therapeutics (CRSP) Pricing Reflecting Gene Editing Potential After Recent Share Pullback

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

Zacks

4 days ago

Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know

Morningstar Research

5 days ago

Analyst Report: CRISPR Therapeutics AG

📈

AI Sentiment

Highly Positive

8/10

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know

Zacks

6 days ago

CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know

CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth

Insider Monkey

6 days ago

CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth

📈

AI Sentiment

Highly Positive

9/10

MT Newswires

6 days ago

Crispr Therapeutics Prices $550 Million Convertible Notes Offering

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

GlobeNewswire

6 days ago

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus

Simply Wall St.

7 days ago

CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus

Share this news page

Share on Social Networks: